A Phase III, Randomized Trial of Magrolimab in Combination With Venetoclax and Azacitidine in Previously Untreated Patients With Acute Myeloid Leukemia Who Are Ineligible For Intensive Chemotherapy (ENHANCE-3)
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA（2023）
关键词
AML, phase III, magrolimab, azacitidine, anti-CD47, acute myeloid leukemia, ENHANCE-3
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要